Squarepoint
CL icon

Squarepoint’s Colgate-Palmolive CL Stock Holding History

Squarepoint’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8M Sell
185,500
-12,400
-6% -$1.11M 0.02% 819
2025
Q4 		$15.6M Sell
197,900
-70,700
-26% -$5.54M 0.02% 859
2025
Q3 		$21.5M Buy
268,600
+68,300
+34% +$5.83M 0.02% 705
2025
Q2 		$18.2M Buy
200,300
+131,900
+193% +$12M 0.02% 806
2025
Q1 		$6.41M Sell
68,400
-194,100
-74% -$17.4M 0.01% 1283
2024
Q4 		$23.9M Buy
262,500
+112,800
+75% +$10.8M 0.02% 684
2024
Q3 		$15.5M Sell
149,700
-37,000
-20% -$3.77M 0.02% 715
2024
Q2 		$18.1M Buy
186,700
+5,800
+3% +$535K 0.03% 633
2024
Q1 		$16.3M Buy
180,900
+75,900
+72% +$6.43M 0.03% 711
2023
Q4 		$8.37M Buy
105,000
+58,900
+128% +$4.43M 0.02% 1048
2023
Q3 		$3.28M Sell
46,100
-44,600
-49% -$3.33M 0.01% 1456
2023
Q2 		$6.99M Buy
90,700
+75,000
+478% +$5.81M 0.02% 887
2023
Q1 		$1.18M Buy
+15,700
New +$1.17M ﹤0.01% 1784
2021
Q1 		– Sell
-22,200
Closed -$1.9M – 3170
2020
Q4 		$1.9M Buy
+22,200
New +$1.84M 0.01% 962

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Squarepoint's CL Position: Q1 2026 in Review

Squarepoint reduced its Colgate-Palmolive (CL) stake by 98% in Q1 2026, selling an estimated $105M and leaving 21,427 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Squarepoint first reported a position in CL in Q4 2015 and has held it in 38 quarters since. The position peaked at $116M in Q4 2023. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Squarepoint held 21,427 shares of Colgate-Palmolive worth $1.83M as of Q1 2026.
  • Squarepoint sold 1,174,148 Colgate-Palmolive shares in Q1 2026, an estimated $105M.
  • Colgate-Palmolive made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2245 holding.
  • Squarepoint first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 38 quarters since.
  • Squarepoint's Colgate-Palmolive position peaked at $116M in Q4 2023.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.